Nuclear Medicine
The Griffin Health Nuclear Medicine Department offers a wide range of nuclear medicine studies and is recognized and accredited by the American College of Radiology (ACR) with a three-year accreditation for both Planar and SPECT imaging in General Nuclear Medicine and Nuclear Cardiology. Our Nuclear Medicine Department provides patients with a full complement of general nuclear medicine examinations, including bone, lung, thyroid, cardiac, liver, and renal evaluations.
The Nuclear Medicine suite offers a relaxed environment and attentive staff, making each visit pleasant and comfortable. In keeping with the Hospital’s Planetree Model of Care, the staff provides patients with a thorough explanation of their exam, soft lighting, lumbar cushions for comfort as well as music and aromatherapy.
The Nuclear Medicine Department prides itself on their willingness to accommodate special appointment requests from both physicians and patients. Complimentary valet parking is offered to all out-patients who use Griffin Hospital’s Diagnostic Imaging Services.
These services are offered Monday through Friday. Nuclear Medicine appointments are scheduled through the Central Scheduling Department at (203) 732-7101.
Pluvicto® Theranostics Program – a groundbreaking treatment option for patients with advanced prostate cancer
Pluvicto is an FDA-approved radioligand therapy for the treatment of adult patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with androgen receptor pathway inhibition and taxane-based chemotherapy. This therapy targets prostate-specific membrane antigen (PSMA)-positive cancer cells, delivering a radioactive payload directly to the tumor, while minimizing damage to surrounding healthy tissue.
Person-centered Prostate Cancer Care
The Griffin Health Pluvicto Theranostics program is designed to expand access to a cutting-edge, targeted radioligand therapy, enhance coordination of care for men with advanced prostate cancer, and improve quality of life and potentially extend survival for eligible patients. It offers a person-centered multidisciplinary care model, including physicians in Nuclear Medicine, Medical Oncology, and Radiation Oncology as well as Nuclear Medicine Technologists, nursing staff, and patient navigation teams to ensure safe, effective, and personalized treatment delivery. As part of a continuous care model, Griffin Health offers PSMA PET/CT imaging for patients to confirm their eligibility before beginning therapy.
Contact Us
Griffin is now accepting referrals for its Pluvicto Theranostics program. Referring providers can contact the Nuclear Medicine Department at 203-732-7271 for more information and orders can be faxed to Central Scheduling at 203-732-1559.
More accurate and timely diagnoses of Parkinson’s disease with DaTscan®.
DaTscan® (Ioflupane I 123) is an innovative diagnostic molecular imaging tool used to evaluate dopamine transporter availability in the brain. DaTscan® imaging involves injecting a small amount of the radiopharmaceutical (a specialized drug that has a radioactive component) into the bloodstream, followed by a single-photon emission computed tomography (SPECT) scan to capture detailed images of the brain. This procedure is non-invasive, safe, and typically takes less than an hour to complete.
Person-Centered Diagnostics
With expansion of services to include this type of neuroimaging, Griffin Health is enhancing its ability to assist neurologists, primary care physicians and other specialists in differentiating between Parkinson’s disease and other movement disorders.
Contact Us
Griffin Health is now accepting referrals for DaTscan®. Referring providers can contact the Griffin Nuclear Medicine Department at 203-732-7271 for more information and orders can be faxed to Central Scheduling at 203-732-1559.